نتائج البحث - "Barbara D. Lovasz"

1

Prediction of short- And medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play the more important role?

المساهمون: Gastroenterology and Hepatology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Journal of Crohn's and Colitis, 11(6), 697-705. Elsevier

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Time Factors, Inflammatory bowel diseases, Inflammatory bowel disease, Gastroenterology, Antibodies, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Crohn Disease, Gastrointestinal Agents, Internal medicine, Biosimilar infliximab, medicine, Humans, Prospective Studies, Biosimilar Pharmaceuticals, Crohn's disease, biology, business.industry, C-reactive protein, Area under the curve, Antibodies, Monoclonal, Biosimilar, General Medicine, medicine.disease, Ulcerative colitis, Infliximab, Surgery, C-Reactive Protein, 030220 oncology & carcinogenesis, Area Under Curve, biology.protein, Trough level, 030211 gastroenterology & hepatology, Colitis, Ulcerative, Female, business, Biomarkers, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412291c72fa4753d8db729ffaabff2ac
http://www.scopus.com/inward/record.url?scp=85029301295&partnerID=8YFLogxK

2

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease

المؤلفون: Barbara D. Lovasz, Zakera Shums, Péter Antal-Szalmás, Peter L. Lakatos, Gary L. Norman, Nora Sipeki, Eszter Palyu, György Kovács, Mária Papp, Petra A. Golovics

المصدر: Journal of Crohn's and Colitis. 9:891-898

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e812aa920fea3f1053ca3a994f8f178f
https://doi.org/10.1093/ecco-jcc/jjv127

3

Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity indexes during one year infliximab therapy in pediatric patients with Crohn's disease

المؤلفون: Petra A. Golovics, Antal Dezsőfi, Gyöngyi Kökönyei, András Arató, Kriszta Molnár, Dolóresz Szabó, Peter L. Lakatos, Katalin Eszter Müller, Gábor Veres, Áron Cseh, Mária Papp, Barbara D. Lovasz

المصدر: Journal of Crohn's and Colitis. 8:747-755

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb812e89f38db0a111f18e824ff00971
https://doi.org/10.1016/j.crohns.2013.12.020

View record from ScienceDirect

4

P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort

المصدر: Journal of Crohn's and Colitis. 11:S246-S246

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, business.industry, Gastroenterology, Biosimilar, General Medicine, Infliximab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Cohort, medicine, 030211 gastroenterology & hepatology, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1451cde3c83449d27f5b049df4d3050f
https://doi.org/10.1093/ecco-jcc/jjx002.456

5

P623 Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database

المؤلفون: P. Fadgyas-Freyler, Krisztina Gecse, Zsuzsanna Kurti, Lorant Gonczi, J. Gimesi-Orszagh, Zsuzsanna Vegh, Barbara D. Lovasz, Péter Lakatos, Petra A. Golovics

المصدر: Journal of Crohn's and Colitis. 11:S399-S399

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ed0da92f135001121bd646c91f1eab1a
https://doi.org/10.1093/ecco-jcc/jjx002.747

6

P592 Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort

المصدر: Journal of Crohn's and Colitis. 11:S382-S382

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, business.industry, Immunogenicity, Gastroenterology, Biosimilar, General Medicine, Infliximab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Cohort, medicine, 030211 gastroenterology & hepatology, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a5b0447da7848107e76351081d8ca7c6
https://doi.org/10.1093/ecco-jcc/jjx002.716

7

P145 Measuring access and quality of care indicators in inflammatory bowel disease in a tertiary referral center

المؤلفون: Péter Lakatos, Lorant Gonczi, Zsuzsanna Kurti, Zsuzsanna Vegh, Barbara D. Lovasz, Krisztina Gecse, Petra A. Golovics

المصدر: Journal of Crohn's and Colitis. 11:S149-S149

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Emergency medicine, Gastroenterology, medicine, Referral center, General Medicine, Quality of care, medicine.disease, business, Inflammatory bowel disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4dffcb90615b86212bdab14f7a86179d
https://doi.org/10.1093/ecco-jcc/jjx002.271

8

P411 Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

المؤلفون: Péter Lakatos, T Molnár, Mariann Rutka, Krisztina Gecse, Balázs Szalay, Zsuzsanna Vegh, Petra A. Golovics, Klaudia Farkas, Zsuzsanna Kurti, Barbara D. Lovasz, Lorant Gonczi

المصدر: Journal of Crohn's and Colitis. 11:S286-S286

مصطلحات موضوعية: Drug, medicine.medical_specialty, medicine.diagnostic_test, business.industry, Adalimumab therapy, media_common.quotation_subject, Gastroenterology, Inflammatory Bowel Diseases, General Medicine, Pharmacology, Persistence (computer science), Therapeutic drug monitoring, medicine, Dose intensification, Intensive care medicine, business, media_common

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7c58fb46af2979e3055968aaf52b19b2
https://doi.org/10.1093/ecco-jcc/jjx002.536

9

P309 Impact of rapid access MR on clinical decision making and patient management in Crohn's disease in a tertiary referral center

المؤلفون: Zsuzsanna Vegh, Krisztina Gecse, Lorant Gonczi, Péter Lakatos, Zsuzsanna Kurti, Gábor Rudas, Barbara D. Lovasz, Petra A. Golovics

المصدر: Journal of Crohn's and Colitis. 11:S234-S234

مصطلحات موضوعية: Crohn's disease, medicine.medical_specialty, Pediatrics, business.industry, Gastroenterology, General Medicine, medicine.disease, Patient management, Clinical decision making, Rapid access, Medicine, Referral center, business, Intensive care medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cab7a660081536a0cadc1979a21f536e
https://doi.org/10.1093/ecco-jcc/jjx002.434

10

DOP048 Is hospitalization predicting the disease course in Crohn's disease? Prevalence and predictors of hospitalization and re-hospitalization in Crohn's disease in a population based inception cohort between 2000–2012

المؤلفون: Zsuzsanna Vegh, Istvan Szita, Petra A. Golovics, Barbara D. Lovasz, A. Mohas, B. Szilagyi, M Balogh, M Mandel, Tunde Pandur, Laszlo Lakatos, Péter Lakatos, Lajos S. Kiss

المصدر: Journal of Crohn's and Colitis. 8:S37-S38

مصطلحات موضوعية: Crohn's disease, Pediatrics, medicine.medical_specialty, business.industry, Disease progression, Gastroenterology, General Medicine, Population based, medicine.disease, INCEPTION COHORT, Disease course, Re hospitalization, medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::01fce70bf5dcc292ad66f038d74f3b6c
https://doi.org/10.1016/s1873-9946(14)60073-8

View record from ScienceDirect

تنقيح النتائج